Cresco Labs (CRLBF) Accounts Payables (2019 - 2026)
Cresco Labs (CRLBF) posted Accounts Payables of $14.2 million for Q1 2026, down 14.31% on a QoQ basis from $16.5 million in Q4 2025.
Cresco Labs (CRLBF) Accounts Payables (2019 - 2026) Analysis & Trends
Cresco Labs' Accounts Payables history runs 8 years deep, the most recent figure standing at $14.2 million for Q1 2026.
- Quarterly Accounts Payables changed N/A year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (changed N/A YoY) and the FY2025 annual result came in at $16.5 million, changed N/A from the prior year.
- Accounts Payables was $14.2 million for Q1 2026 at Cresco Labs, down from $16.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $33.3 million in Q1 2022 and bottomed at $14.2 million in Q1 2026.
- A 5-year average of $21.0 million and a median of $18.8 million in 2024 frame the typical range for Accounts Payables.
- Peak annual rise in Accounts Payables reached 10.04% in 2022, while the deepest fall reached 10.04% in 2022.
- Cresco Labs' Accounts Payables stood at $33.3 million in 2022, then decreased by 17.12% to $27.6 million in 2023, then plunged by 30.57% to $19.2 million in 2024, then dropped by 13.65% to $16.5 million in 2025, then declined by 14.31% to $14.2 million in 2026.
- Business Quant data shows CRLBF's Accounts Payables at $14.2 million in Q1 2026, $16.5 million in Q4 2025, and $19.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.17 Mn |
| Dec 31, 2025 | 16.54 Mn |
| Sep 30, 2024 | 19.16 Mn |
| Jun 30, 2024 | 18.79 Mn |
| Mar 31, 2024 | 17.40 Mn |
| Dec 31, 2023 | 27.59 Mn |
| Mar 31, 2022 | 33.29 Mn |
| Dec 31, 2021 | 32.28 Mn |
| Sep 30, 2021 | 25.62 Mn |
| Mar 31, 2021 | 37.00 Mn |
| Dec 31, 2020 | 23.23 Mn |
| Dec 31, 2019 | 62.83 Mn |